MDxHealth SA
MDXH
$1.60
$0.000.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.53% | 32.33% | 50.48% | 73.48% | 140.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.53% | 32.33% | 50.48% | 73.48% | 140.75% |
| Cost of Revenue | 37.09% | 31.35% | 18.70% | 37.84% | 83.42% |
| Gross Profit | 22.46% | 32.99% | 75.40% | 101.72% | 206.54% |
| SG&A Expenses | 2.34% | 12.32% | 13.03% | 16.73% | 60.06% |
| Depreciation & Amortization | -70.40% | -49.84% | 41.81% | -- | -- |
| Other Operating Expenses | 328.50% | 31.03% | -183.19% | -110.43% | 24,233.33% |
| Total Operating Expenses | 14.17% | 19.79% | 15.65% | 22.09% | 67.77% |
| Operating Income | 26.93% | 7.34% | 32.45% | 45.90% | -11.02% |
| Income Before Tax | 36.63% | -8.49% | 12.92% | 26.31% | -41.58% |
| Income Tax Expenses | 4,700.00% | -- | -99.22% | -- | -- |
| Earnings from Continuing Operations | 36.18% | -8.49% | 13.81% | 25.60% | -41.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.18% | -8.49% | 13.81% | 25.60% | -41.58% |
| EBIT | 26.93% | 7.34% | 32.45% | 45.90% | -11.02% |
| EBITDA | 48.88% | 9.89% | 39.24% | 66.23% | -0.23% |
| EPS Basic | 64.10% | -1.47% | 49.66% | 52.79% | -6.00% |
| Normalized Basic EPS | 108.71% | 23.66% | 89.90% | -- | -- |
| EPS Diluted | 64.10% | -1.47% | 49.66% | 52.79% | -6.00% |
| Normalized Diluted EPS | 108.71% | 23.66% | 89.90% | -- | -- |
| Average Basic Shares Outstanding | 77.77% | 6.92% | 71.21% | 57.60% | 33.57% |
| Average Diluted Shares Outstanding | 77.77% | 6.92% | 71.21% | 57.60% | 33.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |